{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:03:49Z","timestamp":1791745429735,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11506-6","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:52:56Z","timestamp":1771660376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative multi-pathway inhibition of breast cancer by micro-and nano-formulated Curcumin"],"prefix":"10.1007","volume":"53","author":[{"given":"Mahmoud","family":"Moawad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9736-6401","authenticated-orcid":false,"given":"Afaf","family":"Altrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada M.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael S.","family":"Abd El Aal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Y.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohab S.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad S.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"issue":"12","key":"11506_CR1","doi-asserted-by":"publisher","first-page":"20091","DOI":"10.3390\/molecules191220091","volume":"19","author":"KIJM Priyadarsini","year":"2014","unstructured":"Priyadarsini KIJM (2014) The chemistry of curcumin: from extraction to therapeutic agent. Molecules 19(12):20091\u201320112","journal-title":"Molecules"},{"key":"11506_CR2","doi-asserted-by":"publisher","first-page":"1603018","DOI":"10.3389\/fimmu.2025.1603018","volume":"16","author":"MT El-Saadony","year":"2025","unstructured":"El-Saadony MT et al (2025) Curcumin, an active component of turmeric: biological activities, nutritional aspects, immunological, bioavailability, and human health benefits-a comprehensive review. Front Immunol 16:1603018","journal-title":"Front Immunol"},{"key":"11506_CR3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3762\/bjnano.15.88","volume":"15","author":"S Uzokboev","year":"2024","unstructured":"Uzokboev S et al (2024) Unveiling the potential of alginate-based nanomaterials in sensing technology and smart delivery applications. Beilstein J Nanotechnol 15:1077\u20131104","journal-title":"Beilstein J Nanotechnol"},{"key":"11506_CR4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ijbiomac.2017.07.064","volume":"105","author":"JJ Jayapal","year":"2017","unstructured":"Jayapal JJ, Dhanaraj SS (2017) Exemestane loaded alginate nanoparticles for cancer treatment: formulation and in vitro evaluation. Int J Biol Macromol 105:416\u2013421","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"11506_CR5","first-page":"753","volume":"65","author":"ES Shaker","year":"2022","unstructured":"Shaker ES et al (2022) Nanocapsulation of Curcumin and its protective effects against oxidative stress and carcinoma HepG2, MCF7 cells. Egypt J Chem 65(6):753\u2013760","journal-title":"Egypt J Chem"},{"issue":"3","key":"11506_CR6","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"11506_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2133.1982.tb04547.x","volume":"106","author":"EM McMillon","year":"1982","unstructured":"McMillon EM, McKenna WB, Milne CM (1982) Guidelines on Preparing a medical report for compensation purposes. Br J Dermatol 106(4):489\u2013494","journal-title":"Br J Dermatol"},{"issue":"7","key":"11506_CR8","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/biomedicines13071604","volume":"13","author":"A Altrawy","year":"2025","unstructured":"Altrawy A et al (2025) Diagnostic and prognostic roles of miR-155 and miR-3173 in breast and ovarian cancer: implications for early detection and personalized treatment. Biomedicines 13(7):1604","journal-title":"Biomedicines"},{"issue":"7\u20138","key":"11506_CR9","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.biocel.2007.05.008","volume":"39","author":"R Bianco","year":"2007","unstructured":"Bianco R et al (2007) Rational bases for the development of EGFR inhibitors for cancer treatment. Int J Biochem Cell Biol 39(7\u20138):1416\u20131431","journal-title":"Int J Biochem Cell Biol"},{"key":"11506_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/1071-5576(95)00013-5","volume":"2","author":"UJ G\u00f6hring","year":"1995","unstructured":"G\u00f6hring UJ et al (1995) Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma. J Soc Gynecol Investig 2:653\u2013659","journal-title":"J Soc Gynecol Investig"},{"issue":"5","key":"11506_CR11","first-page":"1579","volume":"9","author":"CL Arteaga","year":"2003","unstructured":"Arteaga CL, Baselga J (2003) Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice. Clin Cancer Res 9(5):1579\u20131589","journal-title":"Clin Cancer Res"},{"issue":"5","key":"11506_CR12","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3727\/096504003108748348","volume":"13","author":"T Kanematsu","year":"2003","unstructured":"Kanematsu T et al (2003) Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients. Oncol Res 13(5):289\u2013298","journal-title":"Oncol Res"},{"issue":"2","key":"11506_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2325\/jbcs.968","volume":"14","author":"H Bando","year":"2007","unstructured":"Bando H (2007) Vascular endothelial growth factor and bevacitumab in breast cancer. Breast Cancer 14(2):163\u2013173","journal-title":"Breast Cancer"},{"issue":"4","key":"11506_CR14","first-page":"977","volume":"26","author":"S Meunier-Carpentier","year":"2005","unstructured":"Meunier-Carpentier S et al (2005) Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma. Int J Oncol 26(4):977\u2013984","journal-title":"Int J Oncol"},{"issue":"12","key":"11506_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nrc3627","volume":"13","author":"HL Goel","year":"2013","unstructured":"Goel HL, Mercurio AM (2013) VEGF targets the tumour cell. Nat Rev Cancer 13(12):871\u2013882","journal-title":"Nat Rev Cancer"},{"key":"11506_CR16","doi-asserted-by":"crossref","unstructured":"Yang Z et al (2022) Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma [J]. Cancers (Basel), 14 (1): 232. 2022","DOI":"10.3390\/cancers14010232"},{"issue":"10","key":"11506_CR17","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1158\/1535-7163.MCT-07-0079","volume":"6","author":"DR Emlet","year":"2007","unstructured":"Emlet DR et al (2007) Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines. Mol Cancer Ther 6(10):2664\u20132674","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"11506_CR18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1200\/JCO.2005.05.098","volume":"23","author":"KD Miller","year":"2005","unstructured":"Miller KD et al (2005) Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 23(4):792\u2013799","journal-title":"J Clin Oncol"},{"issue":"6","key":"11506_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/jcp-2022-208731","volume":"76","author":"AG Lashen","year":"2023","unstructured":"Lashen AG et al (2023) Expression, assessment and significance of Ki67 expression in breast cancer: an update. J Clin Pathol 76(6):357\u2013364","journal-title":"J Clin Pathol"},{"key":"11506_CR20","doi-asserted-by":"crossref","unstructured":"Thomas LR, Tansey W (2015) Open Access Journal of Science and Technology, MYC and chromatin. 3","DOI":"10.11131\/2015\/101124"},{"issue":"11","key":"11506_CR21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nrm1496","volume":"5","author":"SJ Riedl","year":"2004","unstructured":"Riedl SJ (2004) Y.J.N.r.M.c.b. Shi, molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5(11):897\u2013907","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"11506_CR22","first-page":"515","volume":"68","author":"M Moawad","year":"2025","unstructured":"Moawad M et al (2025) The implications of nanomedicine in cancer therapy: cytotoxic and apoptotic effects of selenium nanoparticles on human leukemia cell lines. Egypt J Chem 68(12):515\u2013523","journal-title":"Egypt J Chem"},{"issue":"4","key":"11506_CR23","doi-asserted-by":"publisher","first-page":"a008656","DOI":"10.1101\/cshperspect.a008656","volume":"5","author":"DR McIlwain","year":"2013","unstructured":"McIlwain DR, Berger T, Mak TW (2013) Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 5(4):a008656","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"22","key":"11506_CR24","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3390\/cells13221838","volume":"13","author":"M Mustafa","year":"2024","unstructured":"Mustafa M et al (2024) Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications. Cells 13(22):1838","journal-title":"Cells"},{"issue":"6","key":"11506_CR25","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3390\/ijms22062935","volume":"22","author":"P \u0141ukasik","year":"2021","unstructured":"\u0141ukasik P, Za\u0142uski M, Gutowska I (2021) Cyclin-Dependent kinases (CDK) and their role in diseases Development-Review. Int J Mol Sci 22(6):2935","journal-title":"Int J Mol Sci"},{"issue":"1","key":"11506_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews HK, Bertoli C, de Bruin RAM (2022) Cell cycle control in cancer. Nat Rev Mol Cell Biol 23(1):74\u201388","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11506_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0091-679X(01)63011-5","volume":"63","author":"HM Shapiro","year":"2001","unstructured":"Shapiro HM (2001) Principles of data acquisition and display. Methods Cell Biol 63:149\u2013167","journal-title":"Methods Cell Biol"},{"key":"11506_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-0716-2736-5_4","volume":"2579","author":"AM Rieger","year":"2022","unstructured":"Rieger AM (2022) Flow cytometry and cell cycle analysis: an overview. Methods Mol Biol 2579:47\u201357","journal-title":"Methods Mol Biol"},{"issue":"4","key":"11506_CR29","first-page":"255","volume":"10","author":"ZH Loh","year":"2015","unstructured":"Loh ZH, Samanta AK (2015) S.J.A.j.o.p.s. Heng, overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm Sci 10(4):255\u2013274","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"11506_CR30","first-page":"13","volume":"1","author":"B Voncina","year":"2009","unstructured":"Voncina B et al (2009) Encapsulation of Rosemary oil in ethylcellulose microcapsules. Text Polym J 1(1):13\u201319","journal-title":"Text Polym J"},{"issue":"16","key":"11506_CR31","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.2174\/138161210791208992","volume":"16","author":"M Kumar Teli","year":"2010","unstructured":"Kumar Teli M, Mutalik S, Rajanikant GK (2010) Nanotechnology and nanomedicine: going small means aiming big. Curr Pharm Design 16(16):1882\u20131892","journal-title":"Curr Pharm Design"},{"issue":"1","key":"11506_CR32","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1038\/s41598-021-81701-x","volume":"11","author":"M Kumari","year":"2021","unstructured":"Kumari M et al (2021) PGMD\/curcumin nanoparticles for the treatment of breast cancer. Sci Rep 11(1):3824","journal-title":"Sci Rep"},{"issue":"2","key":"11506_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s13204-014-0398-y","volume":"5","author":"KA Abd-Elsalam","year":"2015","unstructured":"Abd-Elsalam KA, Khokhlov AR (2015) Eugenol oil nanoemulsion: antifungal activity against fusarium oxysporum f. sp. vasinfectum and phytotoxicity on cottonseeds. Appl Nanosci 5(2):255\u2013265","journal-title":"Appl Nanosci"},{"issue":"12","key":"11506_CR34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/0145-2126(92)90114-M","volume":"16","author":"DC Marks","year":"1992","unstructured":"Marks DC et al (1992) The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells. Leuk Res 16(12):1165\u20131173","journal-title":"Leuk Res"},{"issue":"9","key":"11506_CR35","first-page":"4899","volume":"37","author":"HM Korashy","year":"2017","unstructured":"Korashy HM et al (2017) Sunitinib inhibits breast cancer cell proliferation by inducing apoptosis, cell-cycle arrest and DNA repair while inhibiting NF-\u03baB signaling pathways. Anticancer Res 37(9):4899\u20134909","journal-title":"Anticancer Res"},{"issue":"2","key":"11506_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.canlet.2004.01.008","volume":"208","author":"GR Pillai","year":"2004","unstructured":"Pillai GR et al (2004) Induction of apoptosis in human lung cancer cells by Curcumin. Cancer Lett 208(2):163\u2013170","journal-title":"Cancer Lett"},{"issue":"7","key":"11506_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.prp.2006.02.005","volume":"202","author":"P Potemski","year":"2006","unstructured":"Potemski P et al (2006) Ki-67 expression in operable breast cancer: a comparative study of immunostaining and a real-time RT-PCR assay. Pathology-Research Pract 202(7):491\u2013495","journal-title":"Pathology-Research Pract"},{"issue":"11","key":"11506_CR38","doi-asserted-by":"publisher","first-page":"e0165876","DOI":"10.1371\/journal.pone.0165876","volume":"11","author":"L Saryeddine","year":"2016","unstructured":"Saryeddine L et al (2016) EGF-induced VEGF exerts a PI3K-dependent positive feedback on ERK and AKT through VEGFR2 in hematological in vitro models. PLoS ONE 11(11):e0165876","journal-title":"PLoS ONE"},{"issue":"1","key":"11506_CR39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.advms.2018.08.014","volume":"64","author":"MA Abdel-Mohsen","year":"2019","unstructured":"Abdel-Mohsen MA, Malak CAA, S.J.A.i.M E (2019) Influence of copper (I) nicotinate complex and autophagy modulation on doxorubicin-induced cytotoxicity in HCC1806 breast cancer cells. Adv Med Sci 64(1):202\u2013209","journal-title":"Adv Med Sci"},{"issue":"17","key":"11506_CR40","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.2174\/1871520619666191024122117","volume":"19","author":"ES El-Shafey","year":"2019","unstructured":"El-Shafey ES, Elsherbiny ES (2019) Possible selective cytotoxicity of vanadium complex on breast cancer cells involving pathophysiological pathways. Anticancer Agents Med Chem 19(17):2130\u20132139","journal-title":"Anticancer Agents Med Chem"},{"key":"11506_CR41","unstructured":"Salah e, El-Shafey E, Eslam S (2019) Assessment of vanadium (V) complex cytotoxic effect on breast cancer. Lap lambert academic pubL"},{"key":"11506_CR42","doi-asserted-by":"publisher","first-page":"039463202311763","DOI":"10.1177\/03946320231176396","volume":"37","author":"M Moawad","year":"2023","unstructured":"Moawad M et al (2023) Curcumin nanocapsules effect in apoptotic processes, gene expression, and cell cycle on Hep-G2 cell lines. Immunopathol Pharmacol 37:03946320231176396","journal-title":"Immunopathol Pharmacol"},{"issue":"8","key":"11506_CR43","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS et al (2017) UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19(8):649\u2013658","journal-title":"Neoplasia"},{"issue":"5","key":"11506_CR44","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3390\/biomedicines11051271","volume":"11","author":"R Ali","year":"2023","unstructured":"Ali R et al (2023) Identification of new key genes and their association with breast cancer occurrence and poor survival using in Silico and in vitro methods. Biomedicines 11(5):1271","journal-title":"Biomedicines"},{"issue":"3\u20134","key":"11506_CR45","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","volume":"52","author":"SS Shapiro","year":"1965","unstructured":"Shapiro SS, Wilk MB (1965) An analysis of variance test for normality (complete samples). Biometrika 52(3\u20134):591\u2013611","journal-title":"Biometrika"},{"issue":"328","key":"11506_CR46","first-page":"1484","volume":"64","author":"RA Waller","year":"1969","unstructured":"Waller RA, Duncan DB (1969) A Bayes rule for the symmetric multiple comparisons problem. J Am Stat Assoc 64(328):1484\u20131503","journal-title":"J Am Stat Assoc"},{"key":"11506_CR47","unstructured":"Rashad SE (2025) Potential Clinical Value of Curcumin and Its Therapeutic Benefits in Cancer and Human Health"},{"issue":"1","key":"11506_CR48","first-page":"39","volume":"35","author":"SS Chung","year":"2015","unstructured":"Chung SS, Vadgama JV (2015) Curcumin and Epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3\u2013NF\u03baB signaling. Anticancer Res 35(1):39\u201346","journal-title":"Anticancer Res"},{"issue":"14","key":"11506_CR49","first-page":"5407","volume":"61","author":"JA Foekens","year":"2001","unstructured":"Foekens JA et al (2001) High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Cancer Res 61(14):5407\u20135414","journal-title":"Cancer Res"},{"key":"11506_CR50","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2147\/JEP.S528132","volume":"17","author":"IA Al Khalily","year":"2025","unstructured":"Al Khalily IA, Megantara S, Aulifa DL (2025) Targeting molecular pathways in breast cancer using Plant-Derived bioactive compounds: A comprehensive review. J Exp Pharmacol 17:375\u2013401","journal-title":"J Exp Pharmacol"},{"issue":"7","key":"11506_CR51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrm1962","volume":"7","author":"A Citri","year":"2006","unstructured":"Citri A, Yarden Y (2006) EGF\u2013ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7(7):505\u2013516","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"11506_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4174\/astr.2015.89.1.1","volume":"89","author":"SH Lee","year":"2015","unstructured":"Lee SH et al (2015) Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis. Annals Surg Treat Res 89(1):1","journal-title":"Annals Surg Treat Res"},{"key":"11506_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.lungcan.2016.01.003","volume":"93","author":"CS Tan","year":"2016","unstructured":"Tan CS, Cho BC, Soo RA (2016) Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor-mutant non-small cell lung cancer. Lung Cancer 93:59\u201368","journal-title":"Lung Cancer"},{"issue":"2","key":"11506_CR54","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/15384047.2015.1121344","volume":"17","author":"Z Chen","year":"2016","unstructured":"Chen Z et al (2016) A human IgG-like bispecific antibody co-targeting epidermal growth factor receptor and the vascular endothelial growth factor receptor 2 for enhanced antitumor activity. Cancer Biol Ther 17(2):139\u2013150","journal-title":"Cancer Biol Ther"},{"key":"11506_CR55","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.phrs.2018.11.014","volume":"139","author":"R Roskoski Jr","year":"2019","unstructured":"Roskoski R Jr (2019) Small molecule inhibitors targeting the EGFR\/ErbB family of protein-tyrosine kinases in human cancers. Pharmacol Res 139:395\u2013411","journal-title":"Pharmacol Res"},{"issue":"4","key":"11506_CR56","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.freeradbiomed.2007.05.009","volume":"43","author":"SK Sandur","year":"2007","unstructured":"Sandur SK et al (2007) Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of Curcumin (diferuloylmethane). Free Radic Biol Med 43(4):568\u2013580","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"11506_CR57","first-page":"1266","volume":"16","author":"S Hu","year":"2018","unstructured":"Hu S et al (2018) Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells. Experimental Therapeutic Med 16(2):1266\u20131272","journal-title":"Experimental Therapeutic Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11506-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:03:21Z","timestamp":1771664601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11506-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11506"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11506-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual data outside the publication was mentioned or enrolled in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No competing interest and no conflict between authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"411"}}